Toxicologic pathology is crucial in the identification and characterization
of health effects following exposure to xenobiotics, mainly in toxicity ex
periments in rodents. Regarding regulatory toxicology, histopathology of ly
mphoid organs and tissues is a cornerstone in the identification of immunot
oxic compounds. A 2-tier testing system ii usually employed in which the fi
rst tier is a general screen for (immuno)toxicity and the second tier consi
sts of specific immune function studies, including host resistance tests: o
r mechanistic studies. The role attributed to histopathology of lymphoid or
gans in the updated Organisation for Economic Cooperation and Development a
nd Food and Drug Administration guidelines requires improvement and standar
dization of the histopathology procedures. Optimalization and standardizati
on was started in an international collaborative immunotoxicity study (ICIC
IS). However, several problems were left unaddressed, mostly because of the
few compounds tested in this study. Based on the results of the ICICIS stu
dy and the morphologic changes induced by immunotoxic/immunomodulatory comp
ounds observed in other investigations, suggestions are given to further im
prove the identification and (semi)quantification of histopathologic change
s in lymphoid organs and tissues.